Mental health conditions, including depression and anxiety, have skyrocketed over the past two years during the pandemic. This mental health epidemic has sparked innovation among forward-looking leaders in the pharmaceutical and healthcare industries. Precision’s Cynthia Miller and Maureen Hennessey look at some of the newer innovations on the horizon as well as some of the policy changes in play that will accelerate transformation.

Read the full article here!